Kodiak Sciences Inc.
KODNasdaqCIK 1468748HealthcareFiscal year ends Dec 31
Reports and events: 123 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-3016:39 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-112371 |
| 2026-09-2808:53 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-403481 |
| 2026-08-1316:17 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-349251 |
| 2026-08-1316:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-349107 |
| 2026-06-0417:22 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-257766 |
| 2026-05-0716:15 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-211951 |
| 2026-05-0716:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-211811 |
| 2026-04-2216:14 ET | DEF 14A | Proxy statementPeriod 2026-06-02 | 0001193125-26-170429 |
| 2026-03-3117:02 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-134887 |
| 2026-03-3116:54 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-134854 |
| 2026-03-2721:56 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-127041 |
| 2025-12-1916:22 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-123184 |
| 2025-12-1816:25 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-324882 |
| 2025-11-1316:12 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-280183 |
| 2025-11-1316:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-280125 |
| 2025-08-1316:11 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-108033 |
| 2025-08-1316:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-107982 |
| 2025-06-0316:29 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-134149 |
| 2025-05-1416:34 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-071523 |
| 2025-05-1416:27 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-071474 |
| 2025-04-2216:06 ET | DEF 14A | Proxy statementPeriod 2025-06-02 | 0000950170-25-056722 |
| 2025-03-2716:20 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-046098 |
| 2025-03-2716:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-046067 |
| 2024-11-1416:10 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-127059 |
| 2024-11-1416:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-127029 |
| 2024-08-1416:10 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-097010 |
| 2024-08-1416:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-096985 |
| 2024-06-0616:11 ET | 8-K | 5.07 Shareholder vote results | 0001193125-24-156056 |
| 2024-05-1516:15 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-060483 |
| 2024-05-1516:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-060455 |
| 2024-04-2316:21 ET | DEF 14A | Proxy statementPeriod 2024-06-04 | 0001193125-24-107064 |
| 2024-03-2816:05 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-038025 |
| 2024-03-2807:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-037608 |
| 2023-11-1416:30 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-063767 |
| 2023-11-1416:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-063701 |
| 2023-11-0606:05 ET | 8-K | 8.01 Other events | 0000950170-23-058996 |
| 2023-08-1717:26 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-23-043277 |
| 2023-08-1416:33 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-042479 |
| 2023-08-1416:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-042419 |
| 2023-07-2406:45 ET | 8-K | 2.02 Results of operations; 8.01 Other events | 0000950170-23-033933 |
| 2023-06-0716:02 ET | 8-K | 5.07 Shareholder vote results | 0001193125-23-162502 |
| 2023-05-1516:11 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-022203 |
| 2023-05-1516:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-022193 |
| 2023-04-2516:01 ET | DEF 14A | Proxy statementPeriod 2023-06-06 | 0001193125-23-115275 |
| 2023-03-2816:31 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-010314 |
| 2023-03-2816:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-010303 |
| 2022-11-0916:15 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-023870 |
| 2022-11-0916:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-023842 |
| 2022-08-0917:02 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000950170-22-016151 |
| 2022-08-0916:44 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-016130 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 17:02 ET. Listed shows no prices and gives no investment advice.